Clin2
NCT07398300Possibly a fitRecruiting

How GIP and GLP-1 affect insulin and blood flow in the body

Type 2 DiabetesHealhty

Treatments studied

Part of Hormones & metabolism clinical trials.

This study uses a special full-body PET scan to see how two natural hormones, GIP and GLP-1, affect how your body uses sugar and moves blood. It includes healthy volunteers and people with type 2 diabetes who are on metformin only.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
36 people
Ages
23 years to 64 years
Study type
Interventional

Who can take part

  • Healthy volunteers: 23–50 years old, BMI 20–27, normal blood sugar (HbA1c below 42).
  • People with type 2 diabetes: 23–60 years old, diagnosed for at least 3 months, on metformin only, with higher blood sugar (HbA1c above 53).
  • Healthy controls for the diabetes group: 23–64 years old, normal blood sugar (HbA1c below 42).
  • No anemia, kidney disease, or liver problems.
  • No stomach or bowel surgery (except appendix or gallbladder removal), no major abdominal surgery.
  • No smoking or nicotine products, no claustrophobia, not pregnant or planning pregnancy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06955130Not yet recruiting
Study on how lactate and glycerol affect blood sugar production

This trial looks at how your body uses lactate and glycerol to make new sugar. It may help us understand blood sugar control in people with and without type 2 diabetes.

NCT07053293Recruiting· Early Phase 1
Study on diabetes medication and liver sugar production

This study tests how a type of diabetes medicine called SGLT2 inhibitors affects how the liver makes sugar. It may help researchers better understand how to manage blood sugar in people with type 2 diabetes.

San Antonio, Texas
NCT05960656Recruiting· Phase 1
Study of SGLT2 inhibitor effects on liver sugar production

This trial tests how stopping a type 2 diabetes medication called an SGLT2 inhibitor affects the liver's production of sugar and ketones. It may help understand better ways to manage diabetes.

San Antonio, Texas
NCT05501483Recruiting
Study how fat differences may relate to type 2 diabetes

This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.

Stockholm
NCT06934473Recruiting
How a gut hormone affects blood pressure after eating in healthy adults

This study looks at how a natural gut hormone called GIP affects blood pressure after a meal. It may help find new ways to treat blood pressure problems after eating.

Copenhagen, Hellerup
NCT07687589Enrolling by invitation
Testing a gut hormone for nausea in healthy adults

This study tests whether a natural gut hormone called GIP can reduce nausea by increasing blood flow to the gut. Researchers want to see how this works in healthy people.

Hellerup

Hear when a new Type 2 diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.